Concepedia

Andrew X. Zhu

AX

27

Publications

2.5K

Citations

19

H-Index

1996

Active since

Affiliations

Massachusetts General Hospital(Current)

Harvard University

Dana-Farber Cancer Institute

The University of Texas MD Anderson Cancer Center

National Taiwan University Hospital

Andrew X. Zhu is an author at Massachusetts General Hospital specializing in medicine, oncology, and cancer therapeutics.

ORCID

Top concepts

Publications per year

1996–2024

27

Publications

27

Systemic Therapy for Advanced Hepatocellular Carcinoma: ASCO Guideline

John D. Gordan, Erin B. Kennedy, Ghassan K. Abou‐Alfa et al. · Journal of Clinical Oncology · 2020 · 601 citations

Cabozantinib plus atezolizumab versus sorafenib for advanced hepatocellular carcinoma (COSMIC-312): a multicentre, open-label, randomised, phase 3 trial

Robin Kate Kelley, Lorenza Rimassa, Ann‐Lii Cheng et al. · The Lancet Oncology · 2022 · 494 citations · Full text

YAP Inhibition Restores Hepatocyte Differentiation in Advanced HCC, Leading to Tumor Regression

Julien Fitamant, Filippos Kottakis, Samira Benhamouche et al. · Cell Reports · 2015 · 247 citations · Full text

, , +21

Differentiation of Malignant Thrombus from Bland Thrombus of the Portal Vein in Patients with Hepatocellular Carcinoma: Application of Diffusion-weighted MR Imaging

Onofrio A. Catalano, Garry Choy, Andrew X. Zhu et al. · Radiology · 2009 · 205 citations

Gemcitabine‐associated thrombotic microangiopathy

Benjamin D. Humphreys, Jeff P. Sharman, Joel Henderson et al. · Cancer · 2004 · 178 citations · Full text

Rows per page

1–5 of 27